DexCom (DXCM) Misses Q1 EPS by 6c

DexCom (NASDAQ: DXCM) reported Q1 EPS of ($0.17), $0.06 worse than the analyst estimate of ($0.11). Revenue for the quarter came in at $72.8 million versus the consensus estimate of $71.32 million.

For earnings history and earnings-related data on DexCom (DXCM) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c